Granite Investment Partners’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
Sell
-25,865
Closed -$149K 354
2018
Q4
$149K Hold
25,865
0.01% 328
2018
Q3
$351K Hold
25,865
0.02% 271
2018
Q2
$307K Hold
25,865
0.02% 275
2018
Q1
$291K Sell
25,865
-96,779
-79% -$1.09M 0.02% 266
2017
Q4
$819K Hold
122,644
0.05% 245
2017
Q3
$1M Sell
122,644
-63,934
-34% -$523K 0.06% 212
2017
Q2
$838K Sell
186,578
-8,993
-5% -$40.4K 0.06% 250
2017
Q1
$1.08M Buy
+195,571
New +$1.08M 0.07% 224